An unknown buyer cancelled the acquisition of 23.2% stake in WooGene Bio Co., Ltd. from WooGene B&G Co., Ltd..
December 15, 2020
Share
An unknown buyer agreed to acquire 23.2% stake in WooGene Bio Co., Ltd. from WooGene B&G Co., Ltd. (KOSDAQ:A018620) for KRW 2.9 billion on December 16, 2019. Under the terms of the transaction, WooGene B&G Co. will sell 100,000 shares but will retain the remaining 330,000 shares which corresponds to approximately 76.4% of the shares of WooGene Bio. The transaction is expected to complete on June 30, 2020.
An unknown buyer cancelled the acquisition of 23.2% stake in WooGene Bio Co., Ltd. from WooGene B&G Co., Ltd. (KOSDAQ:A018620) on December 16, 2020.
WooGene B&G Co., Ltd. is a Korea-based company mainly engaged in the manufacture of veterinary drugs. The Companyâs products include anti-infective, bulk materials, probiotics, enzymes, antiparasitics, hormone preparations, vaccines, aquacultures, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, antiphlogistic injections, enhance metabolism injections, diarrhea remedy injections, sedative injections for swine, toxin binders, pigmentation drugs and others. The Company also provides anti-inflammatory enzymes under the brand name SKD, which are used for human beings. The Company distributes its products within domestic market and to overseas markets, including Iran, Vietnam, Philippines, Brazil and others.
WOOGENE B&G CO., LTD 
